Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Romanian Journal of Internal Medicine
Volume 58 (2020): Issue 3 (September 2020)
Open Access
Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer
Zahid Lepara
Zahid Lepara
,
Orhan Lepara
Orhan Lepara
,
Almir Fajkić
Almir Fajkić
,
Damir Rebić
Damir Rebić
,
Jasmin Alić
Jasmin Alić
and
Hajrudin Spahović
Hajrudin Spahović
| Aug 10, 2020
Romanian Journal of Internal Medicine
Volume 58 (2020): Issue 3 (September 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Aug 10, 2020
Page range:
146 - 152
Received:
Feb 14, 2020
DOI:
https://doi.org/10.2478/rjim-2020-0008
Keywords
bladder cancer
,
biomarker
,
oxidative stress
,
cancer progression
,
malondialdehyde
© 2020 Zahid Lepara et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Zahid Lepara
Urology Clinic Clinical Center University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Orhan Lepara
Department of Physiology, Faculty of Medicine, University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Almir Fajkić
Department of Pathophysiology, Faculty of Medicine, University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Damir Rebić
Nephrology Clinic Clinical Center University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Jasmin Alić
Urology Clinic Clinical Center University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Hajrudin Spahović
Urology Clinic Clinical Center University of Sarajevo
Sarajevo, Bosnia and Herzegovina